Top

Published in:

01-03-2020 | Septicemia | IM - COMMENTARY

Internists feel the rhythm

Authors: Federico Biscetti, Maria Anna Nicolazzi, Andrea Flex, Raffaele Landolfi

Published in: Internal and Emergency Medicine | Issue 2/2020

Excerpt

Changes in heart rhythm always fascinated physicians. The first description of these changes dates back to almost a thousand years ago. The characterization of atrial fibrillation (AF) and its association with stroke were described more recently [1, 2]. Although the pathological mechanisms underlying AF are well known, we cannot predict the onset of AF [3‐8]. …

Prystowsky EN (2008) The history of atrial fibrillation: the last 100 years. J Cardiovasc Electrophysiol 19:575–582. https://doi.org/10.1111/j.1540-8167.2008.01184.x CrossRefPubMed

Bloomfield AL (1958) A bibliography of internal medicine: auricular fibrillation. AMA Arch Intern Med 102:302–313CrossRef

Zimetbaum P (2017) Atrial fibrillation. Ann Intern Med 166:ITC33–ITC48. https://doi.org/10.7326/AITC201703070 CrossRefPubMed

Boriani G, Colella J, Imberti J, Fantecchi E, Vitolo M (2019) Female sex and stroke in atrial fibrillation: an intriguing relationship. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02169-2 CrossRefPubMed

Trivioli G (2019) Atrial fibrillation and kidney disease: insights on a close relationship. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02141-0 CrossRefPubMed

Hu WS, Lin CL (2019) Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02089-1 CrossRefPubMed

Hu WS, Lin CL (2019) Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort study. Intern Emerg Med 14:71–76. https://doi.org/10.1007/s11739-018-1950-7 CrossRefPubMed

Zanon F, Giatti S, Zuin M, Marcantoni L (2018) Troponin assessment in patients admitted to the emergency department with atrial fibrillation: which role in daily clinical practice? Intern Emerg Med 13:319–320. https://doi.org/10.1007/s11739-018-1789-y CrossRefPubMed

Di Pasquale G, Mathieu G, Maggioni AP, Fabbri G, Lucci D, Vescovo G et al (2013) Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study. Int J Cardiol 167:2895–2903. https://doi.org/10.1016/j.ijcard.2012.07.019 CrossRefPubMed

10.

Campanini M, Frediani R, Artom A, Pinna G, Valerio A, La Regina M et al (2013) Real-world management of atrial fibrillation in Internal Medicine units: the FA 'FALP' observational study. J Cardiovasc Med 14:26–34. https://doi.org/10.2459/JCM.0b013e328348e5ce CrossRef

11.

Shteinshnaider M, Almoznino-Sarafian D, Alon I, Tzur I, Berman S, Cohen N et al (2012) Atrial Fibrillation at an Internal Medicine Ward: Clinical and Prognostic Implications. J Atr Fibrillation 5:343. https://doi.org/10.4022/jafib.343 CrossRefPubMedPubMedCentral

12.

Bhave PD, Kamel H (2013) New onset of atrial fibrillation in the hospitalized patient. Journal of hospital medicine 8:154–158. https://doi.org/10.1002/jhm.2007 CrossRefPubMed

13.

Potpara TS, Polovina MM, Marinkovic JM, Lip GYH (2013) A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol 168:4744–4749. https://doi.org/10.1016/j.ijcard.2013.07.234 CrossRefPubMed

14.

Heeringa J, Van Der Kuip DAM, Hofman A, Kors JA, Van Herpen G, Stricker BHC et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 27:949–953. https://doi.org/10.1093/eurheartj/ehi825 CrossRefPubMed

15.

Para O, Caruso L, Corbo L, Bacci F, Pasqui N, Pieralli F et al (2019) Risk factors and outcomes of new-onset atrial fibrillation in patients hospitalized in an internal medicine ward: a case-control study. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02151-y CrossRefPubMed

16.

Biscetti F, Pitocco D, Straface G, Zaccardi F, de Cristofaro R, Rizzo P et al (2011) Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice. Clin Sci (Lond) 121:555–564. https://doi.org/10.1042/CS20110043 CrossRef

17.

Giovannini S, Tinelli G, Biscetti F, Straface G, Angelini F, Pitocco D et al (2017) Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects. Cardiovasc Diabetol 16:99. https://doi.org/10.1186/s12933-017-0581-z CrossRefPubMedPubMedCentral

18.

Biscetti F, Straface G, Angelini F, Pitocco D, Landolfi R, Flex A (2017) Association of RANK/RANKL/OPG gene polymorphisms with risk of peripheral arterial disease (PAD) and critical limb ischemia in the general Italian population. Meta Gene 11:85–90. https://doi.org/10.1016/j.mgene.2016.12.001 CrossRef

19.

Biscetti F, Straface G, Pitocco D, Angelini F, Tinelli G, Landolfi R et al (2016) Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia. Eur Rev Med Pharmacol Sci 20:4048–4054PubMed

20.

Biscetti F, Giovannini S, Straface G, Bertucci F, Angelini F, Porreca C et al (2016) RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. European review for medical and pharmacological sciences 20:4574–4580PubMed

21.

Biscetti F, Straface G, Bertoletti G, Vincenzoni C, Snider F, Arena V et al (2015) Identification of a potential proinflammatory genetic profile influencing carotid plaque vulnerability. J Vasc Surg 61:374–381. https://doi.org/10.1016/j.jvs.2014.08.113 CrossRefPubMed

22.

Biscetti F, Straface G, Porreca CF, Bertoletti G, Vincenzoni C, Snider F et al (2015) Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. Cardiovasc Diabetol 14:139. https://doi.org/10.1186/s12933-015-0301-5 CrossRefPubMedPubMedCentral

23.

Biscetti F, Porreca CF, Bertucci F, Straface G, Santoliquido A, Tondi P et al (2014) TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes. Acta Diabetol 51:1025–1032. https://doi.org/10.1007/s00592-014-0664-1 CrossRefPubMed

24.

Biscetti F, Straface G, Giovannini S, Santoliquido A, Angelini F, Santoro L et al (2013) Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. Hum Genet 132:49–55. https://doi.org/10.1007/s00439-012-1224-9 CrossRefPubMed

25.

Straface G, Biscetti F, Pitocco D, Bertoletti G, Misuraca M, Vincenzoni C et al (2011) Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. Stroke 42:3022–3028. https://doi.org/10.1161/STROKEAHA.111.619288 CrossRefPubMed

26.

Flex A, Gaetani E, Angelini F, Sabusco A, Chilla C, Straface G et al (2007) Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Intern Med 262:124–130. https://doi.org/10.1111/j.1365-2796.2007.01791.x CrossRefPubMed

27.

Lazzerini PE, Capecchi PL, Guidelli GM, Selvi E, Acampa M, Laghi-Pasini F (2016) Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date. Drug Des Devel Ther 10:3083–3098. https://doi.org/10.2147/DDDT.S99898 CrossRefPubMedPubMedCentral

28.

Walkey AJ, Hogarth DK, Lip GYH (2015) Optimizing atrial fibrillation management: from ICU and beyond. Chest 148:859–864. https://doi.org/10.1378/chest.15-0358 CrossRefPubMedPubMedCentral

Title: Internists feel the rhythm
Authors: Federico Biscetti
Maria Anna Nicolazzi
Andrea Flex
Raffaele Landolfi
Publication date: 01-03-2020
Publisher: Springer International Publishing
Keywords: Septicemia
Septicemia
Atrial Fibrillation
Rheumatoid Arthritis
Published in: Internal and Emergency Medicine / Issue 2/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-019-02202-4

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Management of peripheral arterial disease in the modern era: an internist “Cup of Tea”

Liver alterations in anorexia nervosa are not caused by insulin resistance

The dangerous consequences of orthostatic hypotension

Cost-effectiveness analysis of different hypertension management strategies

Stigmatisation and resilience in inflammatory bowel disease

Obituary: Peter Rosen (1935–2019)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage